EZZ Life Science Holdings Ltd
ASX:EZZ
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
71.9m AUD |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191.7B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
148.4B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
136.2T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.7B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.1B USD |
Loading...
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
168.5B HKD |
Loading...
|
Market Distribution
| Min | -6 907 100% |
| 30th Percentile | 21.6% |
| Median | 38.3% |
| 70th Percentile | 58.2% |
| Max | 2 095.9% |
Other Profitability Ratios
EZZ Life Science Holdings Ltd
Glance View
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for EZZ Life Science Holdings Ltd is 74.3%, which is below its 3-year median of 76.2%.
Over the last 3 years, EZZ Life Science Holdings Ltd’s Gross Margin has increased from 50% to 74.3%. During this period, it reached a low of 50% on Jun 30, 2022 and a high of 78.6% on Dec 31, 2024.
